Literature DB >> 20127615

Psychopathological rating scales as efficacy parameters in adult ADHD treatment investigations - benchmarking instruments for international multicentre trials.

M Rösler1, W Retz, R-D Stieglitz.   

Abstract

INTRODUCTION: The selection of appropriate instruments in clinical studies is an essential point to detect the effects of pharmacological and/or psychotherapeutic treatments.
METHODS: We performed a Medline search to identify the controlled pharmacological treatment studies and controlled and open psychotherapeutic investigations since 1999 in adult ADHD. The efficacy parameters were collected in order to compare their psychometric properties and psychopathological content.
RESULTS: We identified 21 pharmacological and 6 psychotherapeutic treatment studies. The ADHD-Rating Scale-IV (ADHD-RS-IV), the Conners Adult ADHD Rating Scale-Observer Version (CAARS-O), and the Wender Reimherr Adult Attention Disorder Rating Scale (WRAADDS) are the clinical expert rating scales, which were used most frequently. The Conners Adult ADHD Rating Scale-Self -Report: Short Version (CAARS-S:S) and the Adult ADHD Self-Report Scale (ASRS) are self-report rating instruments which have found general acceptance. DISCUSSION: The instruments offer appropriate psychometric properties. The psychopathological item content of the ADHD-RS-IV and the CAARS-O is focused on inattention, impulsivity and hyperactivity. The WRAADDS comprises additionally emotional symptoms and disorganization. Copyright Georg Thieme Verlag KG Stuttgart New York.

Entities:  

Mesh:

Year:  2010        PMID: 20127615     DOI: 10.1055/s-0029-1242819

Source DB:  PubMed          Journal:  Pharmacopsychiatry        ISSN: 0176-3679            Impact factor:   5.788


  10 in total

1.  Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.

Authors:  Nora D Volkow; Gene-Jack Wang; Dardo Tomasi; Scott H Kollins; Tim L Wigal; Jeffrey H Newcorn; Frank W Telang; Joanna S Fowler; Jean Logan; Christopher T Wong; James M Swanson
Journal:  J Neurosci       Date:  2012-01-18       Impact factor: 6.167

2.  Divergence by ADHD subtype in smoking cessation response to OROS-methylphenidate.

Authors:  Lirio S Covey; Mei-Chen Hu; Judith Weissman; Ivana Croghan; Lenard Adler; Theresa Winhusen
Journal:  Nicotine Tob Res       Date:  2011-06-07       Impact factor: 4.244

3.  Exome sequencing and unrelated findings in the context of complex disease research: ethical and clinical implications.

Authors:  Gholson J Lyon; Tao Jiang; Richard Van Wijk; Wei Wang; Paul Mark Bodily; Jinchuan Xing; Lifeng Tian; Reid J Robison; Mark Clement; Yang Lin; Peng Zhang; Ying Liu; Barry Moore; Joseph T Glessner; Josephine Elia; Fred Reimherr; Wouter W van Solinge; Mark Yandell; Hakon Hakonarson; Jun Wang; William Evan Johnson; Zhi Wei; Kai Wang
Journal:  Discov Med       Date:  2011-07       Impact factor: 2.970

4.  Sleep disturbance, circadian preference and symptoms of adult attention deficit hyperactivity disorder (ADHD).

Authors:  Bogdan Ioan Voinescu; Aurora Szentagotai; Daniel David
Journal:  J Neural Transm (Vienna)       Date:  2012-07-20       Impact factor: 3.575

5.  Event related potentials study of aberrations in voice control mechanisms in adults with attention deficit hyperactivity disorder.

Authors:  Oleg Korzyukov; Natalie Tapaskar; Mark E Pflieger; Roozbeh Behroozmand; Anjli Lodhavia; Sona Patel; Donald A Robin; Charles Larson
Journal:  Clin Neurophysiol       Date:  2014-09-28       Impact factor: 3.708

6.  Long-term functional outcome in adult prison inmates with ADHD receiving OROS-methylphenidate.

Authors:  Ylva Ginsberg; Tatja Hirvikoski; Martin Grann; Nils Lindefors
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-04-21       Impact factor: 5.270

7.  Multiscale assessment of treatment efficacy in adults with ADHD: a randomized placebo-controlled, multi-centre study with extended-release methylphenidate.

Authors:  Wolfgang Retz; Michael Rösler; Claudia Ose; André Scherag; Barbara Alm; Alexandra Philipsen; Roland Fischer; Richard Ammer
Journal:  World J Biol Psychiatry       Date:  2010-12-14       Impact factor: 4.132

8.  Improved attention linked to sustained phenylalanine reduction in adults with early-treated phenylketonuria.

Authors:  Deborah A Bilder; Georgianne L Arnold; David Dimmock; Mitzie L Grant; Darren Janzen; Nicola Longo; Mina Nguyen-Driver; Elaina Jurecki; Markus Merilainen; Gianni Amato; Susan Waisbren
Journal:  Am J Med Genet A       Date:  2021-11-26       Impact factor: 2.578

9.  Comparison of Web-based and paper-based administration of ADHD questionnaires for adults.

Authors:  Oliver Hirsch; Franziska Hauschild; Martin H Schmidt; Erika Baum; Hanna Christiansen
Journal:  J Med Internet Res       Date:  2013-03-21       Impact factor: 5.428

10.  ESCAlate - Adaptive treatment approach for adolescents and adults with ADHD: study protocol for a randomized controlled trial.

Authors:  Toivo Zinnow; Tobias Banaschewski; Andreas J Fallgatter; Carolin Jenkner; Florence Philipp-Wiegmann; Alexandra Philipsen; Wolfgang Retz; Esther Sobanski; Johannes Thome; Michael Rösler
Journal:  Trials       Date:  2018-05-18       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.